| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.033 | 0.9 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.9 |